Cipla Limited today announced its consolidated financial results for the second quarter ended September 30, 2026 (Q2 FY27), reporting a 35% year-on-year (YoY) decline in net profit after tax to...
Orchid Pharma Ltd., a Dhanuka Group company, announced a licensing and supply agreement with Uruguay-based LaboratorioLibra S.A. to commercialize Exblifep® (cefepime/enmetazobactam) across...
Corxel Pharmaceuticals announced today that it has entered into a definitive business combination agreement with AmanatAcquisition Corp. to take its...
Ambuja Neotia Healthcare Venture Ltd (ANHVL) has unveiled plans to establish a 120-bed specialized woman and child care hospital in Howrah, West Bengal, committing an investment...
AbbVie announced the submission of a regulatory application to the European Medicines Agency (EMA) seeking approval for SKYRIZI® (risankizumab) for subcutaneous (SC) induction dosing...
Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic...
In a major regulatory development, the Maharashtra Food and Drug Administration (FDA) has withdrawn its order cancelingthe drug sale license of Cipla Pharma & Life Sciences Ltd’sCarrying and...
Orsini, a specialty pharmacy known for its work in rare disease care, has been named a specialty pharmacy partner for LISRAYA (brepocitinib), a newly...
Shwas Kavach, an initiative aimed at strengthening India's last-mile medical oxygen supply, has received recognition and support from the Office of the Principal Scientific Adviser (PSA) to...